AdaptHealth Corp. (NASDAQ: AHCO) Reports Strong 2023 Performance and Fiscal Year 2024 Guidance

Photo of author
Written By Dean McHugh

AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of patient-centered healthcare-at-home solutions, including home medical equipment and related services, unveils its financial results for the fourth quarter and fiscal year ended December 31, 2023, along with guidance for fiscal year 2024.

Introduction to AdaptHealth Corp.

Credits: DepositPhotos

AdaptHealth Corp. is a national leader in delivering comprehensive healthcare-at-home solutions to patients across the United States. With a focus on home medical equipment, medical supplies, and related services, AdaptHealth serves approximately 4.1 million patients annually. 

Read More: Protagonist Therapeutics Holds Promise as a Resilient Player in the Biopharmaceutical Industry 

Key Financial Results for Fiscal Year 2023

For fiscal year 2023, AdaptHealth reported robust financial performance, characterized by:

  • Net revenue of $3,200.2 million, reflecting a 7.7% increase compared to the previous year, primarily driven by non-acquired growth of 7.3%.
  • Net loss attributable to AdaptHealth Corp. was $678.9 million, largely attributable to a pre-tax write-down of goodwill amounting to $830.8 million.
  • Adjusted EBITDA increased to $670.8 million, marking a 13.0% increase year-over-year.
  • Cash flow from operations surged to $480.7 million, representing a notable increase of 28.6%.
  • Free cash flow soared to $143.2 million, compared to a negative free cash flow of $(17.6) million in the previous year.

Fourth Quarter 2023 Highlights

In the fourth quarter of 2023, AdaptHealth continued its strong performance with the following highlights:

  • Net revenue reached $858.2 million, up 10.0% from the same quarter in the previous year, primarily driven by non-acquired growth of 9.7%.
  • The company reported a net loss attributable to AdaptHealth Corp. of $254.5 million, mainly due to a pre-tax write-down of goodwill totaling $318.9 million.
  • Adjusted EBITDA surged to $204.6 million, reflecting an impressive increase of 40.2% year-over-year.
  • Cash flow from operations witnessed a substantial increase of 60.2%, reaching $155.3 million.
  • Free cash flow turned positive at $66.6 million, compared to a negative free cash flow of $(46.0) million in the same quarter of the previous year.

Also Read: Google Halts Gemini AI Image Generator Amid Historical Inaccuracy Concerns

Fiscal Year 2024 Guidance

For fiscal year 2024, AdaptHealth Corp. provided the following financial guidance:

  • Net revenue is expected to range between $3.25 billion and $3.35 billion.
  • Adjusted EBITDA is projected to be in the range of $650 million to $710 million.
  • Free cash flow is anticipated to range from $150 million to $180 million. 

This guidance excludes any contributions from acquisitions that have not yet closed and assumes no extension of the 75/25 blended Medicare reimbursement rate adjustment in non-rural, non-competitive bid areas.

Management Commentary and Strategic Outlook

Richard Barasch, Chairman and Interim CEO of AdaptHealth, expressed satisfaction with the company’s performance, particularly in the fourth quarter of 2023. 

He highlighted the record revenue of $3.2 billion and the significant increase in Adjusted EBITDA, indicating the success of strategic initiatives aimed at enhancing efficiency. 

Credits: DepositPhotos

Mr. Barasch emphasized AdaptHealth’s commitment to providing essential medical equipment and supplies to millions of patients annually, supported by a dedicated workforce focused on delivering value and improving patient lives. 

AdaptHealth Corp.’s robust financial performance in 2023, coupled with its optimistic guidance for fiscal year 2024, underscores its resilience and strategic focus on driving growth and value creation in the healthcare-at-home sector. 

Read Next: What is Unitil Corporation’s Future Growth Prospects?


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at; the Financial Industry Regulatory Authority (the "FINRA") at, and relevant State Securities Administrator website and the OTC Markets website at The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: and

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.